Hamzaoui Olfa
Department of Intensive Care, Hôpital Antoine Béclère, University Paris-Saclay, Clamart 92141, France.
J Intensive Med. 2021 Nov 14;2(1):3-7. doi: 10.1016/j.jointm.2021.09.004. eCollection 2022 Jan.
Early detection and prompt reversal of sepsis-induced tissue hypoperfusion are key elements while treating patients with septic shock. Fluid administration is widely accepted as the first-line therapy followed by vasopressor use in persistently hypotensive patients or in those with insufficient arterial pressure to ensure adequate tissue perfusion. Recent evidence suggests a beneficial effect of combining fluids with vasopressors in the early phase of sepsis. Compared with fluids alone, combining fluids and vasopressors increases mean systemic pressure and venous return and corrects hypotension better. This approach also limits fluid overload, which is an independent factor of poor outcomes in sepsis. It produces less hemodilution than fluids alone. As a consequence of these effects, combined treatment may improve outcomes in septic shock patients.
在治疗感染性休克患者时,早期发现并迅速纠正脓毒症引起的组织灌注不足是关键要素。液体输注被广泛认为是一线治疗方法,对于持续低血压患者或动脉压不足以确保充足组织灌注的患者,随后使用血管加压药。最近的证据表明,在脓毒症早期将液体与血管加压药联合使用具有有益效果。与单独使用液体相比,联合使用液体和血管加压药可提高平均体循环压力和静脉回流量,并能更好地纠正低血压。这种方法还可限制液体超负荷,而液体超负荷是脓毒症预后不良的一个独立因素。与单独使用液体相比,联合治疗导致的血液稀释更少。由于这些作用,联合治疗可能改善感染性休克患者的预后。